The mechanism of action of TKIs, while remarkably different to that of IFN, is also accompanied by immune system re-activation, suggesting the immune system is not permanently compromised in CML (101, 102). Here, IFNA1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.